CNS Drugs

, Volume 6, Issue 5, pp 358–366 | Cite as

Brain Abscesses

Current Treatment Options
  • Murat Akova
Disease Management


Brain abscesses are relatively infrequent encounters during daily practice. However, clinicians are urged to diagnose the disease early and treat patients promptly because of the high risk of mortality and morbidity associated with any delay.

Since the availability of computed tomography (CT), the diagnosis and treatment of patients with brain abscesses has improved dramatically. The combination of surgical and medical management has reduced the mortality rate for this disease from 40 to 60% in the pre-CT era to the current rate of 0 to 6%. While stereotaxic aspiration and drainage of the abscesses have revolutionised surgical treatment, new broad-spectrum antibacterials with good penetration into the brain abscess cavity have further improved the outcome of treatment. In selected cases, nonsurgical management alone can be completed successfully with various third generation cephalosporins, metronidazole, or β-lactam/β-lactamase inhibitor combinations. By these means, effective treatment has become a reality in multiple cerebral abscesses that have a deep-seated location, a condition that once carried a very high mortality


Metronidazole Infective Endocarditis Bacterial Meningitis Brain Abscess Antibacterial Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Nicolosi A, Hauser WA, Mussico M, et al. Incidence and prognosis of brain abscess in a defined population: Olmstead County, Minnesota, 1935–1981. Neuroepidemiology 1991; 10: 122–31PubMedCrossRefGoogle Scholar
  2. 2.
    McLelland CJ, Craig BF, Crockard HA. Brain abscess in Northern Ireland: a 30 year community review. J Neurol Neurosurg Psychiatry 1978; 41: 1043–7CrossRefGoogle Scholar
  3. 3.
    Chun CH, Johnson JD, Hofstetter M, et al. Brain abscess: a study of 45 consecutive cases. Medicine (Baltimore) 1986; 65: 415–31CrossRefGoogle Scholar
  4. 4.
    Aebi C, Kaufmann F, Schaad UB. Brain abscess in childhood. Longterm experience. Eur J Pediatr 1991; 150: 282–6PubMedCrossRefGoogle Scholar
  5. 5.
    Molinari GF, Smith L, Goldstein MN, et al. Brain abscess from septic cerebral embolism: an experimental model. Neurology 1973; 23: 1205–10PubMedCrossRefGoogle Scholar
  6. 6.
    Swartz MN. Central nervous system infections. In: Finegold SM, George WL, editors. Anaerobic infections in humans. San Diego: Academic Press, 1989: 155–212Google Scholar
  7. 7.
    Wispelwey B, Scheid WM. Brain abscess. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995: 887–900Google Scholar
  8. 8.
    Foreman SD, Smith EE, Ryan NJ, et al. Neonatal Citrobacter meningitis: pathogenesis of cerebral abscess formation. Ann Neurol 1984; 16: 655–9PubMedCrossRefGoogle Scholar
  9. 9.
    Garvey G. Current concepts of bacterial infections of the central nervous system. Bacterial meningitis and bacterial brain abscess. J Neurosurg 1983; 59: 735–44PubMedCrossRefGoogle Scholar
  10. 10.
    Wispelwey B, Scheid WM. Brain abscess. Semin Neurol 1992; 12: 273–8PubMedCrossRefGoogle Scholar
  11. 11.
    Johnes Jr HR, Siekert RG. Neurological manifestations of infective endocarditis: review of clinical and therapeutic challenges. Brain 1989; 112: 1295–315CrossRefGoogle Scholar
  12. 12.
    Caroli M, Arienta C, Rampini PM, et al. Recurrence of brain abscess associated with asymptomatic arteriovenous malformations of the lung. Neurochirurgia (Stuttg) 1992; 35: 167–70Google Scholar
  13. 13.
    Nielsen H, Glydensted C, Harmsen A. Cerebral abscess: aetiology and pathogenesis, symptoms, diagnosis and treatment. Acta Neurol Scand 1982; 65: 609–22PubMedCrossRefGoogle Scholar
  14. 14.
    Westcombe DS, Dorsch NW, Teo C. Management of cerebral abscess in adolescents and adults: experience in the CT-scan area. Acta Neurochir (Wien) 1988; 95: 85–9CrossRefGoogle Scholar
  15. 15.
    Mampalam TJ, Rosenblum ML. Trends in the management of bacterial brain abscesses: a review of 102 cases over 17 years. Neurosurgery 1988; 23: 451–7PubMedCrossRefGoogle Scholar
  16. 16.
    Mamelak AN, Mampalam TJ, Obana WG, et al. Improved management of multiple brain abscesses: a combined surgical and medical approach. Neurosurgery 1995; 36: 76–85PubMedCrossRefGoogle Scholar
  17. 17.
    Lakshmi V, Rao RR, Dinakar I. Bacteriology of brain abscess —observations on 50 cases. J Med Microbiol 1993; 38: 187–90PubMedCrossRefGoogle Scholar
  18. 18.
    Mathisen GE, Meyer RD, Goerge WL, et al. Brain abscess and cerebritis. Rev Infect Dis 1984; 6 Suppl. 5: S101–6PubMedCrossRefGoogle Scholar
  19. 19.
    Richards J, Sisson PR, Hicman JE, et al. Microbiology, chemotherapy and mortality of brain abscess in Newcastle-upon-Tyne between 1979 and 1988. Scan J Infect Dis 1990; 22: 511–8CrossRefGoogle Scholar
  20. 20.
    Scheid WM. Drug delivery to the central nervous system: general principles and relevance to therapy for infections of the central nervous system. Rev Infect Dis 1989; 11 Suppl. 7: S1669–90Google Scholar
  21. 21.
    Lerner PI. Selection of antimicrobial agents in bacterial infections of the central nervous system. Adv Neurol 1964; 6: 169–95Google Scholar
  22. 22.
    Taber LH, Yow MD, Nieberg FG. The penetration of broad-spectrum antibiotics into the cerebrospinal fluid. Ann NY Acad Sci 1967; 145: 473–81PubMedCrossRefGoogle Scholar
  23. 23.
    Feldman WE, Moffit S, Manning NS. Penetration of cefotaxime into cerebrospinal fluid of infants and children with bacterial meningitis. Antimicrob Agents Chemother 1982; 21: 468–71PubMedCrossRefGoogle Scholar
  24. 24.
    Yamamato M, Jimbo M, Ide M, et al. Penetration of intravenous antibiotics into brain abscesses. Neurosurgery 1993; 33: 44–9CrossRefGoogle Scholar
  25. 25.
    Kramer PW, Griffith RS, Campbell RL. Antibiotic penetration of the brain. A comparative study. J Neurosurg 1969; 31: 295–302PubMedCrossRefGoogle Scholar
  26. 26.
    de Louvois J, Gortvai P, Hurley R. Antibiotic treatment of abscesses of the central nervous system. BMJ 1977; 2: 985–7PubMedCrossRefGoogle Scholar
  27. 27.
    Black P, Graybill JR, Charache P. Penetration of brain abscess by systemically administered antibiotics. J Neurosurg 1973; 38: 705–9PubMedCrossRefGoogle Scholar
  28. 28.
    Picardi JL, Lewis HP, Tan JS, et al. Clindamycin concentrations in the central nervous system of primates before and after head trauma. J Neurosurg 1975; 43: 717–20PubMedCrossRefGoogle Scholar
  29. 29.
    Greene BM, Thomas Jr FE, Alford RH. Trimethoprim-sulfamethoxazole and brain abscess. Ann Intern Med 1975; 82: 812–3PubMedGoogle Scholar
  30. 30.
    Levy RM, Gutin PH, Baskin DS, et al. Vancomycin penetration of a brain abscess: case report and review of the literature. Neurosurgery 1986; 18: 633–6Google Scholar
  31. 31.
    Sjölin J, Eriksson N, Arneborn P, et al. Penetration of cefotaxime and desacetylcefotaxime into brain abscesses in humans. Antimicrob Agents Chemother 1991; 35: 2606–10PubMedCrossRefGoogle Scholar
  32. 32.
    Carton JA, Perry F, Maradona JA, et al. Successful treatment of recurrent cerebral empyema and brain abscesses with imipenem. Eur J Clin Microbiol Infect Dis 1989; 6: 578–80Google Scholar
  33. 33.
    de Louvois J, Hurley R. Inactivation of penicillin by purulent exudates. BMJ 1977; 1: 988–1000CrossRefGoogle Scholar
  34. 34.
    Osenbach R, Loftus C. Diagnosis and management of brain abscess. Neurosurg Clin N Am 1992; 3: 403–20PubMedGoogle Scholar
  35. 35.
    Heineman HS, Braude AI, Osterholm JL. Intracranial suppurative disease. Early presumptive diagnosis and successful treatment without surgery. JAMA 1971; 218: 1542–7PubMedCrossRefGoogle Scholar
  36. 36.
    de Louvois J. The bacteriology and chemotherapy of brain abscess. J Antimicrob Chemother 1978; 4: 395–413PubMedCrossRefGoogle Scholar
  37. 37.
    Rosenblum ML, Hoff JT, Norman D, et al. Nonoperative treatment of brain abscesses in selected high-risk patients. J Neurosurg 1980; 52: 217–25PubMedCrossRefGoogle Scholar
  38. 38.
    Leys D, Christiaens JL, Derambure P, et al. Management of focal intracranial infections: is medical treatment better than surgery? J Neurol Neurosurg Psychiatry 1990; 53: 472–5PubMedCrossRefGoogle Scholar
  39. 39.
    Duel P, Siboni K, Jensen TG. Intracranial abscesses in Odense Hospital. Survey of bacteriology, epidemiology, and treatment with antibiotics, 1963–1989. Dan Med Bull 1991; 38: 407–10PubMedGoogle Scholar
  40. 40.
    Warner J, Perkins RL, Cordero L. Metronidazole therapy of anaerobic bacteremia, meningitis, and brain abscess. Arch Intern Med 1979; 139: 167–9PubMedCrossRefGoogle Scholar
  41. 41.
    Sjölin J, Lilja A, Eriksson N, et al. Treatment of brain abscess with cefotaxime and metronidazole: prospective study on 15 consecutive patients. Clin Infect Dis 1993; 17: 857–63PubMedCrossRefGoogle Scholar
  42. 42.
    Dorche G, Lucht F, Bertrand AM, et al. Diffusion of ceftriaxone into the human brain [in French]. Pathol Biol (Paris) 1990; 38: 638–42Google Scholar
  43. 43.
    Green HT, O’Donoghue MA, Shaw MD, et al. Penetration of ceftazidime into intracranial abscess. J Antimicrob Chemother 1989; 24: 431–6PubMedCrossRefGoogle Scholar
  44. 44.
    Bush LM, Calmon J, Johnson CC. Newer penicillins and betalactamase inhibitors. Infect Dis Clin North Am 1989; 3: 571–94PubMedGoogle Scholar
  45. 45.
    Akova M, Akalin HE, Korten V, et al. Treatment of intracranial abscesses: experience with sulbactam/ampicillin. J Chemother 1993; 5: 181–5PubMedGoogle Scholar
  46. 46.
    Wiseman LR, Wagstaff AJ, Brogden RN, et al. Meropenem: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 1995; 50: 73–101PubMedCrossRefGoogle Scholar
  47. 47.
    Kamin M, Biddle D. Conservative management of focal intracerebral infection. Neurology 1981; 31: 103–6PubMedCrossRefGoogle Scholar
  48. 48.
    Weisburg LA. Nonsurgical management of focal intracranial infection. Neurology 1981; 31: 575–80CrossRefGoogle Scholar
  49. 49.
    Levy RM. Brain abscess and subdural empyema. Curr Opin Neurol 1994; 7: 223–8PubMedCrossRefGoogle Scholar
  50. 50.
    Langmayr JJ, Schwarz A, Buchbergeer W, et al. Local amphotericin B for fungal brain abscess [letter]. Lancet 1993; 342: 123PubMedCrossRefGoogle Scholar
  51. 51.
    Rosenblum ML, Mampalam TJ, Pons VG. Controversies in the management of brain abscesses. Clin Neurosurg 1986; 33: 603–32PubMedGoogle Scholar
  52. 52.
    Young RF, Frazee J. Gas within intracranial abscess cavities: an indication for surgical excision. Ann Neurol 1984; 16: 35–9PubMedCrossRefGoogle Scholar
  53. 53.
    Tekkök H, Erbengi A. Management of brain abscess in children: review of 130 cases over a period of 21 years. Child Nerv Syst 1992; 8: 411–6CrossRefGoogle Scholar
  54. 54.
    Epstein F, Whelan M. Cerebritis masquerading as brain abscess: case report. Neurosurgery 1982; 10: 757–9PubMedCrossRefGoogle Scholar
  55. 55.
    Britt RH, Enzmann DR. Clinical stages of human brain abscesses on serial CT scans after contrast infusion. Computerized tomographic, neuropathological, and clinical correlations. J Neurosurg 1983; 59: 972–89PubMedCrossRefGoogle Scholar
  56. 56.
    Koszewski W. Epilepsy following brain abscess. The evaluation of possible risk factors with emphasis on a new concept of epileptic focus formation. Acta Neurochir (Wein) 1991; 113: 110–7CrossRefGoogle Scholar

Copyright information

© Adis International Limited 1996

Authors and Affiliations

  • Murat Akova
    • 1
  1. 1.Department of Medicine, Section of Infectious DiseasesHacettepe University School of MedicineAnkaraTurkey

Personalised recommendations